CL2018002643A1 - Oclusión de fuga de líquido cefalorraquideo. - Google Patents

Oclusión de fuga de líquido cefalorraquideo.

Info

Publication number
CL2018002643A1
CL2018002643A1 CL2018002643A CL2018002643A CL2018002643A1 CL 2018002643 A1 CL2018002643 A1 CL 2018002643A1 CL 2018002643 A CL2018002643 A CL 2018002643A CL 2018002643 A CL2018002643 A CL 2018002643A CL 2018002643 A1 CL2018002643 A1 CL 2018002643A1
Authority
CL
Chile
Prior art keywords
liquid
leak
occlusion
cerebrospinal fluid
fluid leak
Prior art date
Application number
CL2018002643A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002643A1 publication Critical patent/CL2018002643A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
CL2018002643A 2016-03-18 2018-09-14 Oclusión de fuga de líquido cefalorraquideo. CL2018002643A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662310122P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002643A1 true CL2018002643A1 (es) 2019-04-26

Family

ID=58645333

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002643A CL2018002643A1 (es) 2016-03-18 2018-09-14 Oclusión de fuga de líquido cefalorraquideo.

Country Status (9)

Country Link
US (1) US20210023257A1 (enExample)
EP (1) EP3429645A1 (enExample)
JP (1) JP2019508181A (enExample)
CN (1) CN109195640A (enExample)
AU (1) AU2017232550A1 (enExample)
BR (1) BR112018068939A2 (enExample)
CL (1) CL2018002643A1 (enExample)
MX (1) MX2018011201A (enExample)
WO (1) WO2017158435A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4125995A4 (en) 2020-03-31 2024-04-10 3-D Matrix, Ltd. STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
AU2006241123B2 (en) * 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
HUE037994T2 (hu) * 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
CN103800941B (zh) * 2012-11-09 2015-04-22 北京银河巴马生物技术股份有限公司 一种i型胶原材料、脑膜或脊膜生物膜片及其制备方法和应用
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Also Published As

Publication number Publication date
BR112018068939A2 (pt) 2019-01-22
MX2018011201A (es) 2018-11-22
CN109195640A (zh) 2019-01-11
US20210023257A1 (en) 2021-01-28
JP2019508181A (ja) 2019-03-28
EP3429645A1 (en) 2019-01-23
WO2017158435A1 (en) 2017-09-21
AU2017232550A1 (en) 2018-09-27

Similar Documents

Publication Publication Date Title
CL2019000259A1 (es) Anticuerpos, antimiostatina, polipéptidos que contienen regiones fc variantes y métodos de uso.(divisional solicitud 201701584)
MX2018011216A (es) Moléculas pequeñas contra cereblon para mejorar la función efectora de los linfocitos t.
CL2019000261A1 (es) Polipéptidos modificados y usos de los mismos.
DOP2017000031A (es) Anticuerpo monoclonal anti-ctla4 o su fragmento de unión a antígeno, una composición farmacéutica y uso
GT201600168A (es) Conjugados de anticuerpos anti-drosophila similar a delta 3 (anti dll3) y medicamentos para usarse en el tratamiento contra melanoma.
PE20170242A1 (es) Composiciones de portador-anticuerpo y metodos para realizarlas y utilizarlas
AR096449A1 (es) Compuestos poliméricos anfolíticos en aplicaciones subterráneas
MX2016012124A (es) Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
MX2016004865A (es) Metodo y dispositivo para analizar relacion social.
AR100088A1 (es) Fluido de tratamiento
MX2017002273A (es) Dispositivo de infraestructura modular, sistema de infraestructura y método para operar un dispositivo de infraestructura.
PE20151925A1 (es) Anticuerpos anti-igf-1r con abolicion de la union al fcrn y su utilizacion en el tratamiento de enfermedades oculares vasculares
MX2016002371A (es) Agentes activos en la superficie a base de policarbonato alifatico.
AR103215A1 (es) Composición farmacéutica que comprende plasminógeno y usos de este
MX363219B (es) Composición a base de flavonoides para uso farmacéutico, nutricional o cosmético que tiene acción antioxidante potenciada.
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
CL2018002644A1 (es) Oclusión fístula pancreática.
MX2018011652A (es) Lentes de contacto hibridos de hidrogel de silicona-elastomero de silicona.
MX2020003943A (es) Anticuerpo anti-msln y composicion farmaceutica para el tratamiento del cancer que comprende el mismo.
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
AR102541A1 (es) Película autoadhesiva para la fumigación de suelos
MX2020003614A (es) Polimeros de superficie activada.
MX375652B (es) Casete de líquido con seguro de centrado que tiene una tolerancia a la inclinacion mejorada, asi como un aparato de tratamiento de sangre.
AR103329A1 (es) Composición fluida para estimulación en el campo de la producción de petróleo y gas
AR103331A1 (es) Composición fluida para estimulación en el campo de la producción de petróleo y gas